Furmańczyk-Zawiska, A.; Kubiak-Dydo, A.; Użarowska-Gąska, E.; Kotlarek-Łysakowska, M.; Salata, K.; Kolanowska, M.; Świerniak, M.; Gaj, P.; Leszczyńska, B.; Daniel, M.;
et al. Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)—A Series of Cases from a Single Family. J. Pers. Med. 2021, 11, 304.
https://doi.org/10.3390/jpm11040304
AMA Style
Furmańczyk-Zawiska A, Kubiak-Dydo A, Użarowska-Gąska E, Kotlarek-Łysakowska M, Salata K, Kolanowska M, Świerniak M, Gaj P, Leszczyńska B, Daniel M,
et al. Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)—A Series of Cases from a Single Family. Journal of Personalized Medicine. 2021; 11(4):304.
https://doi.org/10.3390/jpm11040304
Chicago/Turabian Style
Furmańczyk-Zawiska, Agnieszka, Anna Kubiak-Dydo, Ewelina Użarowska-Gąska, Marta Kotlarek-Łysakowska, Katarzyna Salata, Monika Kolanowska, Michał Świerniak, Paweł Gaj, Beata Leszczyńska, Maria Daniel,
and et al. 2021. "Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)—A Series of Cases from a Single Family" Journal of Personalized Medicine 11, no. 4: 304.
https://doi.org/10.3390/jpm11040304
APA Style
Furmańczyk-Zawiska, A., Kubiak-Dydo, A., Użarowska-Gąska, E., Kotlarek-Łysakowska, M., Salata, K., Kolanowska, M., Świerniak, M., Gaj, P., Leszczyńska, B., Daniel, M., Jażdżewski, K., Durlik, M., & Wójcicka, A.
(2021). Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)—A Series of Cases from a Single Family. Journal of Personalized Medicine, 11(4), 304.
https://doi.org/10.3390/jpm11040304
